ID   PI51A_HUMAN             Reviewed;         562 AA.
AC   Q99755; A8K4Q0; B4DIN0; Q99754; Q99756;
DT   25-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   15-MAR-2017, entry version 149.
DE   RecName: Full=Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha;
DE            Short=PIP5K1-alpha;
DE            Short=PtdIns(4)P-5-kinase 1 alpha;
DE            EC=2.7.1.68;
DE   AltName: Full=68 kDa type I phosphatidylinositol 4-phosphate 5-kinase alpha;
DE   AltName: Full=Phosphatidylinositol 4-phosphate 5-kinase type I alpha;
DE            Short=PIP5KIalpha;
GN   Name=PIP5K1A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Fetal brain;
RX   PubMed=8955136; DOI=10.1074/jbc.271.51.32937;
RA   Loijens J.C., Anderson R.A.;
RT   "Type I phosphatidylinositol-4-phosphate 5-kinases are distinct
RT   members of this novel lipid kinase family.";
RL   J. Biol. Chem. 271:32937-32943(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH TUT1.
RX   PubMed=18288197; DOI=10.1038/nature06666;
RA   Mellman D.L., Gonzales M.L., Song C., Barlow C.A., Wang P.,
RA   Kendziorski C., Anderson R.A.;
RT   "A PtdIns4,5P2-regulated nuclear poly(A) polymerase controls
RT   expression of select mRNAs.";
RL   Nature 451:1013-1017(2008).
RN   [7]
RP   FUNCTION IN KERATINOCYTE DIFFERENTIATION, SUBCELLULAR LOCATION, AND
RP   IDENTIFICATION IN A COMPLEX WITH CDH1; CTNNB1 AND CTNND1.
RX   PubMed=19158393; DOI=10.1091/mbc.E08-07-0756;
RA   Xie Z., Chang S.M., Pennypacker S.D., Liao E.-Y., Bikle D.D.;
RT   "Phosphatidylinositol-4-phosphate 5-kinase 1alpha mediates
RT   extracellular calcium-induced keratinocyte differentiation.";
RL   Mol. Biol. Cell 20:1695-1704(2009).
RN   [8]
RP   FUNCTION IN CELL MIGRATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   ASP-322 AND ARG-440.
RX   PubMed=20660631; DOI=10.1083/jcb.200911110;
RA   Chao W.-T., Daquinag A.C., Ashcroft F., Kunz J.;
RT   "Type I PIPK-alpha regulates directed cell migration by modulating
RT   Rac1 plasma membrane targeting and activation.";
RL   J. Cell Biol. 190:247-262(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-486, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Catalyzes the phosphorylation of phosphatidylinositol 4-
CC       phosphate (PtdIns4P) to form phosphatidylinositol 4,5-bisphosphate
CC       (PtdIns(4,5)P2). PtdIns(4,5)P2 is involved in a variety of
CC       cellular processes and is the substrate to form
CC       phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3),
CC       another second messenger. The majority of PtdIns(4,5)P2 is thought
CC       to occur via type I phosphatidylinositol 4-phosphate 5-kinases
CC       given the abundance of PtdIns4P. Participates in a variety of
CC       cellular processes such as actin cytoskeleton organization, cell
CC       adhesion, migration and phagocytosis. Required for membrane
CC       ruffling formation, actin organization and focal adhesion
CC       formation during directional cell migration by controlling
CC       integrin-induced translocation of RAC1 to the plasma membrane.
CC       Together with PIP5K1C is required for phagocytosis, but they
CC       regulate different types of actin remodeling at sequential steps.
CC       Promotes particle ingestion by activating WAS that induces Arp2/3
CC       dependent actin polymerization at the nascent phagocytic cup.
CC       Together with PIP5K1B is required after stimulation of G-protein
CC       coupled receptors for stable platelet adhesion. Plays a role
CC       during calcium-induced keratinocyte differentiation. Recruited to
CC       the plasma membrane by the E-cadherin/beta-catenin complex where
CC       it provides the substrate PtdIns(4,5)P2 for the production of
CC       PtdIns(3,4,5)P3, diacylglycerol and inositol 1,4,5-trisphosphate
CC       that mobilize internal calcium and drive keratinocyte
CC       differentiation. Together with PIP5K1C have a role during
CC       embryogenesis. Functions also in the nucleus where acts as an
CC       activator of TUT1 adenylyltransferase activity in nuclear
CC       speckles, thereby regulating mRNA polyadenylation of a select set
CC       of mRNAs. {ECO:0000269|PubMed:18288197,
CC       ECO:0000269|PubMed:19158393, ECO:0000269|PubMed:20660631}.
CC   -!- CATALYTIC ACTIVITY: ATP + 1-phosphatidyl-1D-myo-inositol 4-
CC       phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate.
CC   -!- SUBUNIT: Interacts with RAC1 (By similarity). Interacts with TUT1.
CC       Forms a complex with CDH1/E-cadherin, CTNNB1/beta-catenin and
CC       CTNND1 at the plasma membrane upon calcium stimulation.
CC       {ECO:0000250, ECO:0000269|PubMed:18288197,
CC       ECO:0000269|PubMed:19158393}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane. Cytoplasm {ECO:0000250}.
CC       Nucleus speckle. Cell projection, ruffle. Note=Colocalizes with
CC       RAC1 at actin-rich membrane ruffles. Localizes to nuclear speckles
CC       and associates with TUT1 to regulate polyadenylation of selected
CC       mRNAs.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=PIP5KIalpha2;
CC         IsoId=Q99755-1; Sequence=Displayed;
CC       Name=2; Synonyms=PIP5KIalpha3;
CC         IsoId=Q99755-2; Sequence=VSP_016007, VSP_016008;
CC       Name=3;
CC         IsoId=Q99755-3; Sequence=VSP_016007;
CC       Name=4;
CC         IsoId=Q99755-4; Sequence=VSP_041912, VSP_041913;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart, placenta, skeletal
CC       muscle, kidney and pancreas. Detected at lower levels in brain,
CC       lung and liver.
CC   -!- CAUTION: There is confusion in the literature with
CC       phosphatidylinositol 4-phosphate 5-kinase type I nomenclature due
CC       to the fact that frequently mouse PIP5K1B is named
CC       Phosphatidylinositol 4-phosphate 5-kinase type I alpha.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U78575; AAC50910.1; -; mRNA.
DR   EMBL; U78576; AAC50911.1; -; mRNA.
DR   EMBL; U78577; AAC50912.1; -; mRNA.
DR   EMBL; AK291015; BAF83704.1; -; mRNA.
DR   EMBL; AK295691; BAG58542.1; -; mRNA.
DR   EMBL; AL592424; CAI16386.1; -; Genomic_DNA.
DR   EMBL; AL592424; CAI16387.1; -; Genomic_DNA.
DR   EMBL; AL592424; CAI16388.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53461.1; -; Genomic_DNA.
DR   EMBL; BC007833; AAH07833.1; -; mRNA.
DR   CCDS; CCDS44219.1; -. [Q99755-1]
DR   CCDS; CCDS44220.1; -. [Q99755-4]
DR   CCDS; CCDS44221.1; -. [Q99755-2]
DR   CCDS; CCDS990.1; -. [Q99755-3]
DR   RefSeq; NP_001129108.1; NM_001135636.1. [Q99755-4]
DR   RefSeq; NP_001129109.1; NM_001135637.1. [Q99755-2]
DR   RefSeq; NP_001129110.1; NM_001135638.1. [Q99755-1]
DR   RefSeq; NP_001317618.1; NM_001330689.1.
DR   RefSeq; NP_003548.1; NM_003557.2. [Q99755-3]
DR   UniGene; Hs.655131; -.
DR   UniGene; Hs.661888; -.
DR   ProteinModelPortal; Q99755; -.
DR   SMR; Q99755; -.
DR   BioGrid; 113983; 45.
DR   DIP; DIP-60649N; -.
DR   IntAct; Q99755; 7.
DR   MINT; MINT-1406942; -.
DR   STRING; 9606.ENSP00000357883; -.
DR   BindingDB; Q99755; -.
DR   ChEMBL; CHEMBL5969; -.
DR   GuidetoPHARMACOLOGY; 2164; -.
DR   SwissLipids; SLP:000000553; -. [Q99755-3]
DR   SwissLipids; SLP:000000554; -.
DR   iPTMnet; Q99755; -.
DR   PhosphoSitePlus; Q99755; -.
DR   SwissPalm; Q99755; -.
DR   BioMuta; PIP5K1A; -.
DR   DMDM; 74752158; -.
DR   EPD; Q99755; -.
DR   MaxQB; Q99755; -.
DR   PaxDb; Q99755; -.
DR   PeptideAtlas; Q99755; -.
DR   PRIDE; Q99755; -.
DR   DNASU; 8394; -.
DR   Ensembl; ENST00000349792; ENSP00000271663; ENSG00000143398. [Q99755-3]
DR   Ensembl; ENST00000368888; ENSP00000357883; ENSG00000143398. [Q99755-1]
DR   Ensembl; ENST00000368890; ENSP00000357885; ENSG00000143398. [Q99755-2]
DR   Ensembl; ENST00000441902; ENSP00000415648; ENSG00000143398. [Q99755-4]
DR   GeneID; 8394; -.
DR   KEGG; hsa:8394; -.
DR   UCSC; uc001exi.4; human. [Q99755-1]
DR   CTD; 8394; -.
DR   DisGeNET; 8394; -.
DR   GeneCards; PIP5K1A; -.
DR   HGNC; HGNC:8994; PIP5K1A.
DR   HPA; HPA029366; -.
DR   MIM; 603275; gene.
DR   neXtProt; NX_Q99755; -.
DR   OpenTargets; ENSG00000143398; -.
DR   PharmGKB; PA33327; -.
DR   eggNOG; KOG0229; Eukaryota.
DR   eggNOG; COG5253; LUCA.
DR   GeneTree; ENSGT00760000119184; -.
DR   HOGENOM; HOG000193876; -.
DR   HOVERGEN; HBG052818; -.
DR   InParanoid; Q99755; -.
DR   KO; K00889; -.
DR   OMA; ETEDHMG; -.
DR   OrthoDB; EOG091G0A6L; -.
DR   PhylomeDB; Q99755; -.
DR   TreeFam; TF319618; -.
DR   BioCyc; MetaCyc:HS07047-MONOMER; -.
DR   BRENDA; 2.7.1.68; 2681.
DR   Reactome; R-HSA-1660499; Synthesis of PIPs at the plasma membrane.
DR   Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   SignaLink; Q99755; -.
DR   SIGNOR; Q99755; -.
DR   ChiTaRS; PIP5K1A; human.
DR   GeneWiki; PIP5K1A; -.
DR   GenomeRNAi; 8394; -.
DR   PMAP-CutDB; Q99755; -.
DR   PRO; PR:Q99755; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143398; -.
DR   CleanEx; HS_PIP5K1A; -.
DR   ExpressionAtlas; Q99755; baseline and differential.
DR   Genevisible; Q99755; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0032587; C:ruffle membrane; IDA:UniProtKB.
DR   GO; GO:0052811; F:1-phosphatidylinositol-3-phosphate 4-kinase activity; TAS:Reactome.
DR   GO; GO:0000285; F:1-phosphatidylinositol-3-phosphate 5-kinase activity; TAS:Reactome.
DR   GO; GO:0016308; F:1-phosphatidylinositol-4-phosphate 5-kinase activity; IDA:UniProtKB.
DR   GO; GO:0052810; F:1-phosphatidylinositol-5-kinase activity; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019900; F:kinase binding; IDA:UniProtKB.
DR   GO; GO:0052812; F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity; TAS:Reactome.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB.
DR   GO; GO:0090630; P:activation of GTPase activity; IMP:UniProtKB.
DR   GO; GO:0060326; P:cell chemotaxis; IMP:UniProtKB.
DR   GO; GO:0016477; P:cell migration; NAS:UniProtKB.
DR   GO; GO:0010761; P:fibroblast migration; IEA:Ensembl.
DR   GO; GO:0048041; P:focal adhesion assembly; IMP:UniProtKB.
DR   GO; GO:0006650; P:glycerophospholipid metabolic process; TAS:ProtInc.
DR   GO; GO:0030216; P:keratinocyte differentiation; TAS:UniProtKB.
DR   GO; GO:0006909; P:phagocytosis; TAS:UniProtKB.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   GO; GO:0008654; P:phospholipid biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0072661; P:protein targeting to plasma membrane; IMP:UniProtKB.
DR   GO; GO:0014066; P:regulation of phosphatidylinositol 3-kinase signaling; TAS:Reactome.
DR   GO; GO:0097178; P:ruffle assembly; IMP:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   Gene3D; 3.30.800.10; -; 1.
DR   Gene3D; 3.30.810.10; -; 1.
DR   InterPro; IPR023610; PInositol-4-P-5-kinase.
DR   InterPro; IPR027483; PInositol-4-P-5-kinase_C.
DR   InterPro; IPR002498; PInositol-4-P-5-kinase_core.
DR   InterPro; IPR027484; PInositol-4-P-5-kinase_N.
DR   PANTHER; PTHR23086; PTHR23086; 1.
DR   Pfam; PF01504; PIP5K; 1.
DR   SMART; SM00330; PIPKc; 1.
DR   PROSITE; PS51455; PIPK; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell membrane; Cell projection;
KW   Complete proteome; Cytoplasm; Isopeptide bond; Kinase; Membrane;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Transferase; Ubl conjugation.
FT   CHAIN         1    562       Phosphatidylinositol 4-phosphate 5-kinase
FT                                type-1 alpha.
FT                                /FTId=PRO_0000185456.
FT   DOMAIN       81    449       PIPK. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00781}.
FT   MOD_RES     486    486       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    103    103       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT   VAR_SEQ      30     52       ASGIKRPMASEVLEARQDSYISL -> SGIKRPMASE (in
FT                                isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8955136}.
FT                                /FTId=VSP_016007.
FT   VAR_SEQ      41     52       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041912.
FT   VAR_SEQ     382    410       HMGGIPARNSKGERLLLYIGIIDILQSYR -> Q (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041913.
FT   VAR_SEQ     455    504       LKPSPSKKFRSGSSFSRRAGSSGNSCITYQPSVSGEHKAQV
FT                                TTKAEVEPG -> C (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8955136}.
FT                                /FTId=VSP_016008.
FT   MUTAGEN     322    322       D->N: Does not affect targeting of RAC1
FT                                to the plasma membrane; when associated
FT                                with Q-440.
FT                                {ECO:0000269|PubMed:20660631}.
FT   MUTAGEN     440    440       R->Q: Does not affect targeting of RAC1
FT                                to the plasma membrane; when associated
FT                                with N-322.
FT                                {ECO:0000269|PubMed:20660631}.
FT   CONFLICT    257    257       K -> E (in Ref. 2; BAG58542).
FT                                {ECO:0000305}.
SQ   SEQUENCE   562 AA;  62633 MW;  A8F7988EB73506A0 CRC64;
     MASASSGPSS SVGFSSFDPA VPSCTLSSAA SGIKRPMASE VLEARQDSYI SLVPYASGMP
     IKKIGHRSVD SSGETTYKKT TSSALKGAIQ LGITHTVGSL STKPERDVLM QDFYVVESIF
     FPSEGSNLTP AHHYNDFRFK TYAPVAFRYF RELFGIRPDD YLYSLCSEPL IELCSSGASG
     SLFYVSSDDE FIIKTVQHKE AEFLQKLLPG YYMNLNQNPR TLLPKFYGLY CVQAGGKNIR
     IVVMNNLLPR SVKMHIKYDL KGSTYKRRAS QKEREKPLPT FKDLDFLQDI PDGLFLDADM
     YNALCKTLQR DCLVLQSFKI MDYSLLMSIH NIDHAQREPL SSETQYSVDT RRPAPQKALY
     STAMESIQGE ARRGGTMETD DHMGGIPARN SKGERLLLYI GIIDILQSYR FVKKLEHSWK
     ALVHDGDTVS VHRPGFYAER FQRFMCNTVF KKIPLKPSPS KKFRSGSSFS RRAGSSGNSC
     ITYQPSVSGE HKAQVTTKAE VEPGVHLGRP DVLPQTPPLE EISEGSPIPD PSFSPLVGET
     LQMLTTSTTL EKLEVAESEF TH
//
